184 related articles for article (PubMed ID: 27630281)
1. Silencing Prion Protein in HT29 Human Colorectal Cancer Cells Enhances Anticancer Response to Fucoidan.
Yun CW; Yun S; Lee JH; Han YS; Yoon YM; An D; Lee SH
Anticancer Res; 2016 Sep; 36(9):4449-58. PubMed ID: 27630281
[TBL] [Abstract][Full Text] [Related]
2. Differences in cell death and cell cycle following fucoidan treatment in high-density HT-29 colon cancer cells.
Kim IH; Kwon MJ; Nam TJ
Mol Med Rep; 2017 Jun; 15(6):4116-4122. PubMed ID: 28487956
[TBL] [Abstract][Full Text] [Related]
3. Fucoidan inhibits the migration and proliferation of HT-29 human colon cancer cells via the phosphoinositide-3 kinase/Akt/mechanistic target of rapamycin pathways.
Han YS; Lee JH; Lee SH
Mol Med Rep; 2015 Sep; 12(3):3446-3452. PubMed ID: 25998232
[TBL] [Abstract][Full Text] [Related]
4. ShRNA-mediated gene silencing of heat shock protein 70 inhibits human colon cancer growth.
Zhong MA; Zhang H; Qi XY; Lu AG; You TG; Gao W; Guo XL; Zhou ZQ; Yang Y; Wang CJ
Mol Med Rep; 2011; 4(5):805-10. PubMed ID: 21725599
[TBL] [Abstract][Full Text] [Related]
5. Effect of Heat Treatment on the Antitumor Activity of Lactoferrin in Human Colon Tumor (HT29) Model.
Li HY; Yang HG; Li P; Wang YZ; Huang GX; Xing L; Wang JQ; Zheng N
J Agric Food Chem; 2019 Jan; 67(1):140-147. PubMed ID: 30418775
[TBL] [Abstract][Full Text] [Related]
6. Antitumor Effects of Fucoidan on Human Colon Cancer Cells via Activation of Akt Signaling.
Han YS; Lee JH; Lee SH
Biomol Ther (Seoul); 2015 May; 23(3):225-32. PubMed ID: 25995820
[TBL] [Abstract][Full Text] [Related]
7. Utility of RNAi-mediated prnp gene silencing in neuroblastoma cells permanently infected by prions: potentials and limitations.
Kim Y; Han B; Titlow W; Mays CE; Kwon M; Ryou C
Antiviral Res; 2009 Nov; 84(2):185-93. PubMed ID: 19748523
[TBL] [Abstract][Full Text] [Related]
8. STAT3-targeting RNA interference inhibits pancreatic cancer angiogenesis in vitro and in vivo.
Huang C; Jiang T; Zhu L; Liu J; Cao J; Huang KJ; Qiu ZJ
Int J Oncol; 2011 Jun; 38(6):1637-44. PubMed ID: 21479358
[TBL] [Abstract][Full Text] [Related]
9. Glucose-regulated protein 78 silencing down-regulates vascular endothelial growth factor/vascular endothelial growth factor receptor 2 pathway to suppress human colon cancer tumor growth.
Kuo LJ; Hung CS; Chen WY; Chang YJ; Wei PL
J Surg Res; 2013 Nov; 185(1):264-72. PubMed ID: 23759331
[TBL] [Abstract][Full Text] [Related]
10. Melatonin and 5-fluorouracil co-suppress colon cancer stem cells by regulating cellular prion protein-Oct4 axis.
Lee JH; Yun CW; Han YS; Kim S; Jeong D; Kwon HY; Kim H; Baek MJ; Lee SH
J Pineal Res; 2018 Nov; 65(4):e12519. PubMed ID: 30091203
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of cellular prion protein inhibited the proliferation and invasion and induced apoptosis of Marek's disease virus-transformed avian T cells.
Wan X; Yang R; Liu G; Zhu M; Zhang T; Liu L; Wu R
J Vet Sci; 2016 Jun; 17(2):171-8. PubMed ID: 26243599
[TBL] [Abstract][Full Text] [Related]
12. Anticancer effects of KI-10F: a novel compound affecting apoptosis, angiogenesis and cell growth in colon cancer.
Hong SW; Jung KH; Choi MJ; Kim DY; Lee HS; Zheng HM; Li GY; El-Deeb IM; Park BS; Lee SH; Hong SS
Int J Oncol; 2012 Nov; 41(5):1715-22. PubMed ID: 22941304
[TBL] [Abstract][Full Text] [Related]
13. Cysteine-Rich Intestinal Protein 1 Silencing Inhibits Migration and Invasion in Human Colorectal Cancer.
He G; Zou L; Zhou L; Gao P; Qian X; Cui J
Cell Physiol Biochem; 2017; 44(3):897-906. PubMed ID: 29179181
[TBL] [Abstract][Full Text] [Related]
14. Role of HSPA1L as a cellular prion protein stabilizer in tumor progression via HIF-1α/GP78 axis.
Lee JH; Han YS; Yoon YM; Yun CW; Yun SP; Kim SM; Kwon HY; Jeong D; Baek MJ; Lee HJ; Lee SJ; Han HJ; Lee SH
Oncogene; 2017 Nov; 36(47):6555-6567. PubMed ID: 28759037
[TBL] [Abstract][Full Text] [Related]
15. The 18-kDa translocator protein, formerly known as the peripheral-type benzodiazepine receptor, confers proapoptotic and antineoplastic effects in a human colorectal cancer cell line.
Shoukrun R; Veenman L; Shandalov Y; Leschiner S; Spanier I; Karry R; Katz Y; Weisinger G; Weizman A; Gavish M
Pharmacogenet Genomics; 2008 Nov; 18(11):977-88. PubMed ID: 18806692
[TBL] [Abstract][Full Text] [Related]
16. Antitumor effects of novel compound, guttiferone K, on colon cancer by p21Waf1/Cip1-mediated G(0) /G(1) cell cycle arrest and apoptosis.
Kan WL; Yin C; Xu HX; Xu G; To KK; Cho CH; Rudd JA; Lin G
Int J Cancer; 2013 Feb; 132(3):707-16. PubMed ID: 22733377
[TBL] [Abstract][Full Text] [Related]
17. Sialylation of epidermal growth factor receptor regulates receptor activity and chemosensitivity to gefitinib in colon cancer cells.
Park JJ; Yi JY; Jin YB; Lee YJ; Lee JS; Lee YS; Ko YG; Lee M
Biochem Pharmacol; 2012 Apr; 83(7):849-57. PubMed ID: 22266356
[TBL] [Abstract][Full Text] [Related]
18. Lactoferrin Exerts Antitumor Effects by Inhibiting Angiogenesis in a HT29 Human Colon Tumor Model.
Li HY; Li M; Luo CC; Wang JQ; Zheng N
J Agric Food Chem; 2017 Dec; 65(48):10464-10472. PubMed ID: 29112400
[TBL] [Abstract][Full Text] [Related]
19. A small interfering RNA targeting vascular endothelial growth factor inhibits Ewing's sarcoma growth in a xenograft mouse model.
Guan H; Zhou Z; Wang H; Jia SF; Liu W; Kleinerman ES
Clin Cancer Res; 2005 Apr; 11(7):2662-9. PubMed ID: 15814647
[TBL] [Abstract][Full Text] [Related]
20. COX-2 silencing enhances tamoxifen antitumor activity in breast cancer in vivo and in vitro.
Du Y; Shi A; Han B; Li S; Wu D; Jia H; Zheng C; Ren L; Fan Z
Int J Oncol; 2014 Apr; 44(4):1385-93. PubMed ID: 24535190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
